Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.48 |
| ▸ | TSHR | P16473 | 4/20 | 0.48 |
| ▸ | CA2 | P00918 | 3/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | HTR1A | P08908 | 1/20 | 0.34 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.34 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.34 |
| ▸ | DRD3 | P35462 | 1/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2444490 | 0.76 | ALDH1A1 (0.50) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| SCHEMBL8763250 | 0.76 | ALDH1A1 (0.50) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| SCHEMBL15969565 | 0.76 | ALDH1A1 (0.50) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| SCHEMBL78111 | 0.76 | ALDH1A1 (0.50) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| SCHEMBL387001 | 0.76 | — | — | |
| SCHEMBL3884493 | 0.76 | ALDH1A1 (0.68) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| SCHEMBL331210 | 0.76 | ALDH1A1 (0.45) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| Water SCHEMBL9947734 | 0.73 | ALDH1A1 (0.65) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| Ammonia Solution, Strong SCHEMBL20492542 | 0.73 | ALDH1A1 (0.65) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| SCHEMBL524297 | 0.73 | ALDH1A1 (0.65) | ALDH1A1TDP1CYP3A4TSHRCA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105118920-B | Photo-electric conversion element and solid camera head | 索尼公司 | 2017-10-17 | — | — | CN | claimed |
| US-9711737-B2 | Photoelectric conversion element and solid-state imaging device | SONY CORPORATION (JP) | 2017-07-18 | — | — | US | claimed |
| US-20160049595-A1 | PHOTOELECTRIC CONVERSION ELEMENT AND SOLID-STATE IMAGING DEVICE | SONY CORPORATION (JP) | 2016-02-18 | — | — | US | claimed |
| CN-105118920-A | Photoelectric conversion element and solid-state imaging device | SONY CORP | 2015-12-02 | — | — | CN | claimed |
| US-9123901-B2 | Photoelectric conversion element and solid-state imaging device | SONY CORPORATION (JP) | 2015-09-01 | — | — | US | claimed |
| EP-2478981-B1 | SILVER-(CONJUGATED COMPOUND) COMPLEX | SUMITOMO CHEMICAL CO (JP) | 2020-12-23 | — | — | EP | disclosed |
| CN-105118920-B | Photo-electric conversion element and solid camera head | 索尼公司 | 2017-10-17 | — | — | CN | disclosed |
| US-9711737-B2 | Photoelectric conversion element and solid-state imaging device | SONY CORPORATION (JP) | 2017-07-18 | — | — | US | disclosed |
| US-9704612-B2 | Composition of silver-conjugated compound composite | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-07-11 | — | — | US | disclosed |
| US-9412487-B2 | Silver-(conjugated compound) composite | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-08-09 | — | — | US | disclosed |
| CN-103003974-B | Photoelectric conversion element and solid-state imaging device | 索尼公司 | 2016-06-22 | — | — | CN | disclosed |
| US-20160049595-A1 | PHOTOELECTRIC CONVERSION ELEMENT AND SOLID-STATE IMAGING DEVICE | SONY CORPORATION (JP) | 2016-02-18 | — | — | US | disclosed |
| EP-2478981-A1 | SILVER-(CONJUGATED COMPOUND) COMPLEX | Sumitomo Chemical Co., Ltd (JP) | 2012-07-25 | — | — | EP | disclosed |
| US-20120168693-A1 | SILVER-(CONJUGATED COMPOUND) COMPOSITE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-07-05 | — | — | US | disclosed |
| US-7902207-B2 | Process for production of amines | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-03-08 | — | — | US | disclosed |
| US-7781425-B2 | Guanidine compound and asymmetric reaction using the same | TAKASAGO INTERNATIONAL COPORATION (JP) | 2010-08-24 | — | — | US | disclosed |
| US-20080154036-A1 | Guanidine Compound and Asymmetric Reaction Using the Same | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2008-06-26 | — | — | US | disclosed |
| US-7312347-B2 | Substituted optically active disphosphine compound | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-12-25 | — | — | US | disclosed |
| US-20070142639-A1 | Process for production of amines | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-06-21 | — | — | US | disclosed |
| US-20070073065-A1 | Substituted optically active disphosphine compound | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080154036-A1 | Guanidine Compound and Asymmetric Reaction Using the Same | GEMIN5, PRMT5, SMS | ALDH1A1 2039/4885TDP1 3674/4885CYP3A4 148/4885 |
| US-20070142639-A1 | Process for production of amines | SMS, CCNT1, PEAK1 | ALDH1A1 1001/4885TDP1 2750/4885CYP3A4 507/4885 |
| US-20070073065-A1 | Substituted optically active disphosphine compound | DHPS, DOHH, DHODH | ALDH1A1 277/4885TDP1 3874/4885CYP3A4 374/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.